-
Homoharringtonine Source:
- Plant-derived alkaloid indigenous to: Eastern Asia/China, Japan, and India
- The bark of Cephalotaxus harringtonia var. drupacea (Sieb & Zucc.)
- Natural homoharringtonine is extracted from the bark of Cephalotaxus sp.
- Semi-synthetic homoharringtonine is known as Omacetaxine Mepesuccinate
- Common names include: Plum Yew, Japanese Plum Yew, Harrington Plum Yew, and Cow Tail Pine
-
Homoharringtonine chemistry:
- Tertiary amine
- Cephalotaxine derivative in which the secondary alcohol group has been esterified with different naturally occurringacids
- Homoharringtonine is a homologue (one additional methylene function in esterchain) of harringtonine
-
Omacetaxine Mepesuccinate (Homoharringtonine) MOA:
- Induces apoptosis (programmed celldeath) in myeloid cells via inhibition of protein synthesis
- Inhibits angiogenesis
- Occurs as a result of reversible inhibition of ribosome/elongation factor complex
- Acts independently of tyrosine kinase inhibitors
-
Omacetaxine Mepesuccinate (Homoharringtonine) Applications:
Potentially in CML, AML and MDS (myelodysplastic syndrome [increased risk to transformation to AML]
Phase 3 studies in CML
-
Omacetaxine Mepesuccinate (Homoharringtonine) special AEs:
Nonhematologic toxicities were infrequently observed
-
Eribulin Source:
Synthetic macrocyclic ketone analog of halichondrin B, a large macrocyclic polyether first isolated from the sponge Halichondria okadai in 1986
**Halichondrin B was highly cytotoxic in murine leukemia cells**
-
Eribulin Chemistry:
- Macrocyclic polyether
- Consists of “right-hand portion” of Halichondrin B structure
- Acetate, malonate, methylmalonate metabolites
-
Eribulin MOA:
- Tubulin depolymerizer
- Disrupts polymerization of themicrotubules necessary in mitosis
- Binds near the Vinca domain
-
Eribulin Applications:
Advanced, “heavily-treated”, metastatic breast carcinoma
November 15, 2010 – FDA approves for thetreatment of patients with metastaticbreast cancer who have received at leasttwo prior chemotherapy regimens for latestagedisease
-
Major Biosynthetic Precursor of Eribulin:
HALICHONDRIN B
-
Bleomycin Source:
Mixture of cytotoxic glycopeptide antibiotics isolated as their water soluble sulfate salts from cultures of a strain of Streptomyces verticillus
-
Bleomycin Chemistry:
- Isolated as a blue-colored Cu(II) coordinated complex
- The Cu+2 is removed prior to marketing via catalytic reduction
- Increases cost but frees up critical functional groups for chelation with intracellular Fe+2
- Bleomycin complexes (chelates) in vitro with divalent and trivalent cations
-
Bleomycin MOA:
- Contains an iron-binding region and aDNA-binding region at opposite ends of the molecule
- Iron is a mandatory co-factor for free radical generation and resulting cytotoxicity of bleomycin
- Cytotoxicity results from activated oxygenfree radical species which produce single- and double-strand DNA breaks
-
Bleomycin Applications:
- Hodgkin’s and Non-Hodgkin’s lymphomas
- Germ cell tumors
- Head and neck squamous cell carcinoma
- Skin, cervix, vulvar squamous cell carcinoma
-
Bleomycin special AEs:
- Pulmonary Toxicity (most severe toxicity): Pneumonitis & Pulmonary Fibrosis
- Dermatologic Rxns: desquamation, rash, hyperpigmentation, hyperkeratosis
-
Dactinomycin Source:
Major antibiotic of a mixture ofactinomycins produced by strains of Streptomyces parvulus
-
Dactinomycin Chemistry:
- Heteroaromatic chromopeptide
- Planar phenoxazone chromophore
-
Dactinomycin MOA:
- Preferentially binds to guanine-cytosinebase pairs
- Binds to single- & double-stranded DNA as an intercalator with formation of toxic oxygen free radicals that promote strand breaks
-
Dactinomycin Common Applications:
- Wilms’ tumor
- Rhabdomyosarcoma
- Choriocarcinoma
- Ewing’s sarcoma
-
Dactinomycin Special AEs:
- Dermatological: hyperpigmentation & extravasation
- Red-orange color of bodily fluids
-
Romidepsin Source:
First isolated from cultures of Chromobacterium violaceum by Fujisawa Pharm. in 1990
-
Romidepsin Chemistry:
- Depsipeptide: A peptide having both amide and ester bonds
- Bicyclic peptide consisting of 4 amino acid residues and a novel acid
-
Romidepsin MOA:
Histone deacetylase inhibitor (HDI)
HDIs possess anti-tumor activity: Regulate gene transcription or translation; Induce cell cycle arrest and apoptosis through histone hyperacetylation
-
Romidepsin Common Applications:
- Cutaneous T-cell Lymphoma (CTCL)
- Peripheral T-cell Lymphoma (CTCL)
-
Romidepsin Special AEs:
- Asthenia (weakness)
- ECG changes -- requires periodic monitoring of ECG and serum electrolytes
-
Mitomycin Source:
One member of a group of antitumor antibiotics isolated from cultures of Streptomyces caespitosus
-
Mitomycin Chemistry:
- Mitosanes (1,2-disubstituted indoloquinones)
- Pyrrolo [1,2-a] indole nucleus
- Contains quinone, aziridine, and carbamate functions
- Only compound in nature to contain an aziridine ring
- Water soluble, Blue-violet colored solution
- Unstable in both acidic and alkaline media
- Limited stability of reconstituted solutions
-
Mitomycin MOA:
INHIBITS TRANSCRIPTION BY TARGETING DNA-DEPENDENT RNA POLYMERASE
-
Mitomycin Common Applications:
- Disseminated adenocarcinoma of the stomach and pancreas
- Unlabeled used: Superficial bladder cancer; Adjunct to surgical excision in primary or recurrent pterygia (web-like superficial growth on the subconjunctiva)
-
Mitomycin special AEs:
- Dose-related Hemolytic-uremic syndrome
- Dermatologic Rxns
- Interstitial pneumonitis
-
Apaziquone Source/Chemistry:
- Synthetic indoloquinone
- Analog of mitomycin C
-
Major Biosynthetic Precursor of Apaziquone:
Mitomycin C
-
Apaziquone MOA:
- Bioreductive prodrug
- Intracellular reductases catalyze the conversion to active metabolites in hypoxic cells
- Active metabolites alkylate DNA producing apoptotic cell death
-
Apaziquone Common Applications:
Therapy of non-muscle invasive (superficial) bladder cancer via intravesical instillation following transurethral resection (TUR) of bladder tumor
-
Streptozocin Source:
Fermentation product of Streptomyces achromogenes
-
Streptozocin Chemistry:
- Pale gold water soluble nitrosourea
- 2-Deoxy-2-(3-methyl-3-nitrosoureido)-Dglucopyranose
- Mixture of alpha and beta anomers, with solutions undergoing mutarotation
-
Streptozocin MOA:
Decomposes to form carbonium ions that are electrophilic and can alkylate or carbamoylate various purines or pyrimadines to form adducts involved in inter- or intrastrand DNA cross-linking
Also, methylates guanine at the O-6 position and irreversibly inactivates DNA-repair enzyme, mammalian alkyl transferase
-
Streptozocin Common Applications:
Metastatic islet pancreatic carcinoma
-
Streptozocin Special AEs:
- Very severe nausea and vomiting
- Nephrotoxicity
- Myelotoxicity is rare
-
Doxorubicin Source:
First isolated from cultures of Streptomyces peucetius var. caesius
-
Doxorubicin Chemistry:
- Cytotoxic glycosidic anthracycline
- Part of the rhodomycin group of compounds
- Today is prepared via semi-synthesis from daunorubicin
- Planar anthraquinone nucleus linked glycosidically to an aminosugar (daunosamine)
-
This compound is a major biosynthetic precursor of Daunorubicin
Doxorubicin
-
Doxorubicin MOA:
- Intercalates between base pairs in DNA double helix, affecting DNA and RNA synthesis
- Generates reactive oxygen intermediates and free radicals
- Inhibits Topoisomerase-II
-
Doxorubicin Common Applications:
**MANY**
- Acute lymphoblastic leukemia (ALL)
- Hodgkin’s and non-Hodgkin’s lymphomas
- Carcinomas: Breast, Ovarian, Bladder
- Sarcomas: Kaposi’s sarcoma (AIDS-related)
-
Doxorubicin Special AEs:
- Cardiovascular (both acute and chronic): Arrhythmias & CHF
- Discoloration of body fluids: Urine turns Red-to-orange
- Strong vesicant
-
Dexrazoxane Chemistry:
- S-(+)- isomer of razoxane
- A diamine and a di-imide
- A cyclic derivative of EDTA
-
Dexrazoxane MOA:
A cardioprotective intracellular chelating agent that reduces (or prevents) the incidence and severity of cardiotoxicity associated with anthracycline-derived antitumor agents
-
Epirubicin Source:
- Semisynthetic analog of doxorubicin
- Water soluble HCl salt is employed
-
Epirubicin Chemistry:
- C-4’ epimer of doxorubicin
- Same physical/chemical properties as doxorubicin
- Red-orange color
-
Epirubicin MOA:
Same as Doxorubicin: inhibits topoisomerase-II
-
Epirubicin Common Applications:
- Adjuvant for early stage breast cancer that has spread to the regional (axillary) lymph nodes but has been treated surgically with removal of all known tumor
- Metastatic breast carcinoma
- Gastric carcinoma
-
Epirubicin Special AEs:
Same as Doxorubicin (cardiotoxicity & discoloration of bodily fluids) with slightly less cardiotoxicity
-
Daunorubicin Source:
- Originally isolated from cultures of Streptomyces peucetius var. caesius
- Also obtained from cultures of Streptomyces coeruleorubidus
-
Daunorubicin Chemistry:
- A C-8 deoxy-doxorubicin derivative
- Same physical and chemical properties as doxorubicin
- Red-orange color
- Water soluble HCl salt used
-
Daunorubicin MOA:
same as doxorubicin: inhibits Topoisomerase-II
-
Daunorubicin Common Applications:
- Acute leukemias (lymphoblastic andmyelogenous)
- Kaposi’s Sarcoma (AIDS-related)
-
Daunorubicin Special Adverse Effects:
Same as Doxorubicin: Cardiotoxicity and bodily-fluid discoloration
-
Idarubicin Source:
- Synthetic analog of daunorubicin
- 1-Demethoxydaunorubicin ---- Demethoxylation flattens the aromatic ring facilitating intercalation between base pairs
- High degree of lipophilicity affords increased rate of cellular uptake
- Same phys/chem properties as doxorubicin
-
Idarubicin MOA:
- Same as doxorubicin: inhibits topoisomerase-II
- Partially overcomes MDR
-
Idarubicin Common Applications:
- Acute leukemias (AML, ALL)
- Chronic leukemia (CML) in blast crisis
-
Idarubicin Special AEs:
Same as Doxorubicin: cardiotoxicity and bodily-fluid discoloration
-
Valrubicin Source/Chemistry:
- Semisynthetic analog of doxorubicin
- Valeric acid ester of the N-trifluoroacetylamide of doxorubicin ---- Basic amine nitrogen of doxorubicin is lost, and replaced with neutral amidic nitrogen; Water solubility is low
- High degree of lipophilicity affords increased rate of cellular uptake
- Supplied in Cremophor EL/Dehydrated Alcohol mixture as a solution
-
Valrubicin MOA:
Same as Doxorubicin: inhibits topoisomerase II (but is less bound to DNA)
-
Valrubicin Common Applications:
Intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients who would be poor candidates for immediate cystectomy
-
Valrubicin Special AEs:
- Local reactions: Irritation, Urgency, Frequency, Dysuria
- Systemic reactions are uncommon as total recovery of voided anthracyclines is 99%,with systemic exposure being negligible
-
Sabarubicin Chemistry:
A C-1 demethoxy-doxorubicin disaccharide
-
Sabarubicin MOA:
- Same as Doxorubicin: More marked topoisomerase II mediated cleavage
- Significant activity against a number of tumors
-
Mitoxantrone Source:
an analog of ametantrone
-
Mitoxantrone Chemistry:
- A dihydroxyametantrone
- Blue-black solid
- Forms water soluble HCl salt
- Not glycosylated (as doxorubicin family)
- Amphoteric
-
Mitoxantrone MOA:
Same as Doxorubicin: inhibits Topoisomerase II
-
Mitoxantrone Common Applications:
- Acute myelogenous leukemia (AML)
- Advanced hormone-refractory prostatecancer
- Non-Hodgkin’s lymphoma
- Reduction of neurologic disability orfrequency of relapses in multiple sclerosis(MS) patients (uncommon application)
-
Mitoxantrone Special AEs:
Same as Doxorubicin: Cardiotoxicity (CHF)
-
Pixantrone Source:
- A synthetic aza-anthracenedione
- Discovered in a search for novel heteroanalogs of anthracenediones
-
Pixantrone Chemistry:
- Blue solid
- Forms water soluble HCl salt
- Pixantrone = pyridine
- Not glycosylated (as doxorubicin family)
-
Pixantrone MOA:
A novel major groove binder
-
Pixantrone Common Applications:
Relapsed or refractory Non-Hodgkins lymphoma
-
Pixantrone Special AEs:
- MINIMAL CARDIOTOXICITY
- Incidence of severe adverse effects was similar between the drug and the control arm
|
|